Favicon of Qventus

Erlanger adds 220 surgical cases per month with Qventus AI-powered surgical growth platform

“Erlanger adds 220 surgical cases per month with Qventus AI-powered surgical growth platform” documents a Surgical & Perioperative Care deployment in Hospital & Health System at Erlanger. www.qventus.com reports additional surgical cases per month: 220; this directory has not independently verified that result.

Maintained by Peter Korpak, Founder & Chief AnalystHow evidence is checked

Evidence at a glance

Evidence status:
Automated evidence gate passed
Deployment timeframe:
Not reported by source
Reported outcome metrics:
3 cited below
Directory entry published:
Source link checked:

The source-link check confirms reachability, not independent re-verification of every claim.

220Additional Surgical Cases Per Month
5xAnnualized ROI
~25%Robotic Surgical Volume Growth (YoY)

Source-reported figures — cited source: www.qventus.com

The Challenge

Erlanger faced significant OR inefficiency, with over 30% of block time going unused and robotic rooms being filled with non-robotic cases. Independent surgeons were taking cases to competing facilities, while schedulers spent hours on manual phone calls and faxing. Leaders lacked real-time visibility into referral patterns, splitter surgeons, and true growth opportunities.

The Solution

Erlanger deployed Qventus' Surgical Growth Solution, which uses ML-driven automation to continuously optimize OR scheduling. Key components included TimeFinder (predicting case lengths and matching available slots), Capacity Assistant (proactively engaging surgeons to release blocks weeks in advance), Strategic Marketing Assistant (automatically marketing time to best-fit surgeons), and a Robotics Optimizer for maximizing robotic asset utilization.

Results

Within six months of go-live in June 2025, Erlanger added 220 surgical cases per month compared to the same period the prior year. Nearly 12 additional OR hours per room per month were generated through intelligent block release nudges, and robotic surgical volume grew nearly 25% year-over-year for engaged surgeons. Break-even was achieved in under 3 months, with the health system on track for a 5x annualized ROI.

Key Takeaways

  • Deep implementation partnership—embedding the vendor team in frontline clinical workflows—was critical to broad adoption across 98 surgeons in a relatively short period.
  • ML-driven nudges that respect individual surgeon preferences (rather than blasting all available slots) drove higher engagement and meaningful behavior change.
  • Targeting strategic objectives like robotic utilization directly in the scheduling automation enabled Erlanger to maximize high-value asset ROI alongside volume growth.

Share:

Vendor

Favicon of QventusQventus

Details

Company Size
Enterprise
Company
Erlanger
Evidence status
Automated evidence gate passed
Deployment timeframe
Not reported by source
Directory entry published
Source link checked

Cited source

www.qventus.com

Have a similar implementation?

Share your customer's AI results and link it to your vendor profile.

Submit a case study →